<DOC>
	<DOCNO>NCT02547350</DOCNO>
	<brief_summary>The purpose study evaluate efficacy prophylactic intravesical chemotherapy ( different chemotherapy drug dosage regimen ) prevention bladder recurrence nephroureterectomy upper tract urothelial carcinoma ( UTUC ) .</brief_summary>
	<brief_title>Prophylactic Intravesical Chemotherapy Prevent Bladder Tumors After Nephroureterectomy Primary Upper Urinary Tract Urothelial Carcinomas</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<mesh_term>Pirarubicin</mesh_term>
	<criteria>1 . Patients clinically diagnose UTUC 2 . Treated radical nephroureterectomy 1 . Distant metastasis 2 . Prior history bladder synchronous bladder cancer 3 . Administration neoadjuvant chemotherapy 4 . Presence severe complication .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>